Should People Eat Food with Ingredients they Can't Pronounce?

Tamara Thomas and Dr. Monique Nugent tackle whether the popular saying "If you can't pronounce it, don't eat it," still holds value for mindful eating.

Food Myths - Episode #108

Dr. Cory Rice Discusses Help for Patients After Stopping GLP-1s

Cory Rice, DO, a practitioner specializing in Functional Medicine and anti-aging medicine, and Chief Clinical Advisor for Biote Medical, talks about the next steps for patients who have discontinued GLP-1s but still require assistance with reversing their health conditions.

Interviews with Key Healthcare Opinion Leaders - Episode #107

Dr. Alessandra Maleddu Discusses Desmoid Tumors

Dr. Alessandra Maleddu, a Medical Oncologist and Sarcoma Specialist at the University of Colorado, talks about desmoid tumors. She highlights methods for enhancing patient diagnosis through imaging techniques and the importance of referring patients to a sarcoma specialist.

Interviews with Key Healthcare Opinion Leaders - Episode #106

April Christina on Navigating Endometriosis and Infertility

After years of misdiagnoses and, later, infertility, April Christina was diagnosed with stage four endometriosis. She talks about the challenges of getting properly diagnosed as a Black woman, the emotional toll of infertility, and her experience with IVF. April Christina also emphasizes the importance of support systems, faith, and advocacy, as well as the resources available through Fertility Out Loud.

Conversations with Patient Advocates - Episode #105

Dr. Gregg Sylvester explains why the 2024-2025 flu season is one of the worst

Gregg Sylvester, MD, Chief Health Officer of CSL Seqirus, details why this year’s flu season is particularly severe.

Interviews with Key Healthcare Opinion Leaders - Episode #104

Dr. Andrew Hertler explains the FDA’s decision to narrow approvals for PD-1 inhibitors

Dr. Andrew Hertler, Senior Advisor / Chief Medical Officer – emeritus for Evolent, explains ODAC’s September 2024 vote to support the FDA’s decision to restrict the use of PD-1 inhibitor drugs such as Opdivo, Keytruda, and Tevimbra&nbsp;for PD-L1-negative stomach cancer and esophageal cancer, and his support of using biomarkers to predict outcomes.

Interviews with Key Healthcare Opinion Leaders - Episode #103

Dr. Bruce Dorr on What Menopausal Women With BRCA Should Know About HRT

Dr. Bruce Dorr, MD, FPMRS, FACOG, discusses menopausal women who possess gene mutations, such as BRCA1/2 or PTEN, and what they need to know about Hormone Replacement Therapy.

Interviews with Key Healthcare Opinion Leaders - Episode #102

Should the FDA Educate the Public about its GRAS Loophole?

Tamara Thomas and Dr. Monique Nugent debate whether the FDA should actively inform the public that its FDA GRAS loophole allows companies to test and report on their food products.

FDA GRAS Loophole - Should Buyers Beware? - Episode #101

Dr. Terra Wonsettler Discusses Cardiotoxicity Among Cancer Drugs

Terra Wonsettler, PharmD, Vice President of Clinical Evidence, Policy, and Oncology Pharmacy at Evolent, discusses the cardiotoxicity of many cancer drugs, cancer patient awareness of these risks, and the accelerated cancer drug approval process.

Urban Health Weekly

Follow